Herpes Simplex Virus 2, DNA [real-time PCR]

A semi-quantitative study used to diagnose infection caused by Herpes Simplex Virus type 2 by determining the genetic material (DNA) of the pathogen in the biological material being examined. Herpes Simplex Virus type 2 predominantly affects the mucous membranes of the genital organs.
In medical practice, the analysis is usually prescribed for the diagnosis of genital herpes; differential diagnosis of morphological elements of sexually transmitted diseases; confirmation of the diagnosis in the presence of symptoms of herpetic lesions (ulcers, vesicles in the genital area) or neonatal herpes; examination of people suffering from diseases that increase the risk of developing complications of herpetic infection (HIV, eczema, severe burns, chemotherapy for oncological diseases, immunosuppressive drugs used in organ transplantation); preventive examination of healthy people; examination of patients preparing for organ transplantation; examination of patients with a burdened transfusion history; when planning pregnancy.

Within 2 days. The specified time does not include the day of biomaterial collection